Will the price of Sotoraxibu increase in 2024?

Sotoracib (AMG510) is a targeted drug that targets the KRAS G12C mutation and is used to treat patients with KRAS who have received at least one systemic treatment in the past. Patients with G12Cmutated locally advanced or metastatic non-small cell lung cancer (NSCLC).

SotorasibuThe price will not increase in 2024. Sotoracib was approved for marketing by Nikkei US FDA in May 2021. There are currently many generic drugs officially marketed overseas. Sotoracib produced by Bangladesh Everest Pharmaceuticals is relatively early, and the retail price of 120 mg 56 tablets is around 4000. In 2023, sotolasibu produced by Lucius Pharmaceuticals in Laos was approved by the Food and Drug Administration for marketing. The retail price of 120mg56 tablets2 was more than 1,000. Therefore, as more and more pharmaceutical factories produce, prices will fall.

SotoracibThe most common adverse reactions(≥ 20%)are diarrhea, musculoskeletal pain, nausea, fatigue, hepatotoxicity and cough. The most common laboratory abnormalities (≥ 25%)are lymphopenia, decreased hemoglobin, increased aspartate aminotransferase, increased alanine aminotransferase, decreased calcium, increased alkaline phosphatase, increased urinary protein, and decreased sodium. SotoraxibInstructionsThe recommended dose is 960mg, taken orally once daily. When960 mg Sotolaxibu and a high-fat, high-calorie meal(contains approximately 800 to 1000 calories, respectively, from protein The calories from mass, carbohydrates and fat are 150, 250 and 500 to 600Calories)When administered together, patients' AUC AUC0-24 hours increased by 25% when administered under fasted conditions. A box of officially marketed generic drugs ranges from 2 to 4 more than 1,000. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.